Left ventricular assist device management in the ICU

Critical Care Medicine

Volumn 42, Issue 1, 2014, Pages 158-168

  Pratt, Alexandra K ^a   Shah, Nimesh S ^a   Boyce, Steven W ^a  

^a WASHINGTON HOSPITAL CENTER   (United States)

Author keywords

continuous flow left ventricular assist device; HeartMate II; HeartWare; left ventricular assist device

Indexed keywords

ACETYLSALICYLIC ACID; ADRENALIN; AMIODARONE; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; ATROPINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; HEPARIN; HYPERTENSIVE FACTOR; LEPIRUDIN; LIDOCAINE; MEXILETINE; MILRINONE; RECOMBINANT BLOOD CLOTTING FACTOR 7A; SILDENAFIL; SOTALOL; VASODILATOR AGENT; WARFARIN;

ANTICOAGULATION; AORTA VALVE REGURGITATION; AORTA VALVE STENOSIS; ARTICLE; ASSISTED CIRCULATION; BLEEDING; BLOOD PRESSURE MONITOR; CANNULA; CARDIOGENIC SHOCK; CARDIOVASCULAR RISK; CARDIOVERSION; CATHETERIZATION; CLASSIFICATION ALGORITHM; CONTINUOUS FLOW LEFT VENTRICULAR ASSIST DEVICE; DEFIBRILLATION; DEVICE INFECTION; ECHOCARDIOGRAPHY; HEART ARREST; HEART ARRHYTHMIA; HEART FAILURE; HEART PERFORMANCE; HEART RIGHT VENTRICLE; HEART RIGHT VENTRICLE FAILURE; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE TACHYCARDIA; HEMOLYSIS; HUMAN; HYPOTENSION; HYPOVOLEMIA; IMPLANTATION; INTENSIVE CARE UNIT; INTENSIVIST; LEFT VENTRICULAR ASSIST DEVICE; MEDICAL DEVICE COMPLICATION; MORBIDITY; PATIENT MONITORING; PHYSIOLOGICAL PROCESS; POSTOPERATIVE CARE; PRIORITY JOURNAL; PULMONARY ARTERY; PULMONARY HYPERTENSION; RESUSCITATION; SEPSIS; STERNOTOMY; TERMINAL CARE; THROMBOEMBOLISM; THROMBOSIS;

EID: 84891558924     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/01.ccm.0000435675.91305.76     Document Type: Article

References (100)

1. Roger VL, Go AS, Lloyd-Jones DM, et al: Heart disease and stroke statistics-2012 update: A report from the American Heart Association. Circulation 2012; 125:e2-e220
2. Roger VL, Weston SA, Redfield MM, et al: Trends in heart failure incidence and survival in a community-based population. JAMA 2004; 292:344-350
3. Costanzo MR, Mills RM, Wynne J: Characteristics of "Stage D" heart failure: Insights from the Acute Decompensated Heart Failure National Registry Longitudinal Module (ADHERE LM). Am Heart J 2008; 155:339-347
4. Taylor DO, Stehlik J, Edwards LB, et al: Registry of the International Society for Heart and Lung Transplantation: Twenty-sixth official adult heart transplant report-2009. J Heart Lung Transplant 2009; 28:1007-1022
5. Miller LW, Pagani FD, Russell SD, et al: Use of a continuous-flow device in patients awaiting heart transplantation. N Engl J Med 2007; 357:885-896
6. Rogers JG, Aaronson KD, Boyle AJ, et al: Continuous flow left ventricular assist device improves functional capacity and quality of life of advanced heart failure patients. J Am Coll Cardiol 2010; 55:1826-1834
7. Slaughter MS, Rogers JG, Milano CA, et al: Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med 2009; 361:2241-2251
8. Kirklin JK, Naftel DC, Pagani FD, et al: Long-term mechanical circulatory support (destination therapy): On track to compete with heart transplantation J Thorac Cardiovasc Surg 2012; 144:584-603
9. Williams ML, Trivedi JR, McCants KC, et al: Heart transplant vs left ventricular assist device in heart transplant-eligible patients. Ann Thorac Surg 2011; 91:1330-1333; discussion 1333-1334
10. Kirklin JK, Naftel DC, Kormos RL, et al: The Fourth INTERMACS Annual Report: 4,000 implants and counting. J Heart Lung Transplant 2012; 31:117-126
11. Frazier OH: Current status of cardiac transplantation and left ventricular assist devices. Tex Heart Inst J 2010; 37:319-321
12. Lund LH, Gabrielsen A, Tiren L, et al: Derived and displayed power consumption, flow, and pulsatility over a range of HeartMate II left ventricular assist device settings. ASAIO J 2012; 58:183-190
13. Butler KC, Dow JJ, Litwak P, et al: Development of the Nimbus/University of Pittsburgh innovative ventricular assist system. Ann Thorac Surg 1999; 68:790-794
14. Christensen DM: Physiology of continuous-flow pumps. AACN Adv Crit Care 2012; 23:46-54
15. Griffith BP, Kormos RL, Borovetz HS, et al: HeartMate II left ventricular assist system: From concept to first clinical use. Ann Thorac Surg 2001; 71:S116-S120; discussion S114-S116
16. DeBakey ME, Teitel ER: Use of the MicroMed DeBakey VAD for the treatment of end-stage heart failure. Expert Rev Med Devices 2005; 2:137-140
17. John R: Current axial-flow devices-the HeartMate II and Jarvik 2000 left ventricular assist devices. Semin Thorac Cardiovasc Surg 2008; 20:264-272
18. Timms D: A review of clinical ventricular assist devices. Med Eng Phys 2011; 33:1041-1047
19. Wilson SR, Givertz MM, Stewart GC, et al: Ventricular assist devices the challenges of outpatient management. J Am Coll Cardiol 2009; 54:1647-1659
20. Larose JA, Tamez D, Ashenuga M, et al: Design concepts and principle of operation of the HeartWare ventricular assist system. ASAIO J 2010; 56:285-289
21. Ozbaran M, Yagdi T, Engin C, et al: New circulatory support system: Heartware. Transplant Proc 2012; 44:1726-1728
22. Tuzun E, Roberts K, Cohn WE, et al: In vivo evaluation of the HeartWare centrifugal ventricular assist device. Tex Heart Inst J 2007; 34:406-411
23. Anyanwu AC: Technique for less invasive implantation of Heartmate II left ventricular assist device without median sternotomy. Semin Thorac Cardiovasc Surg 2011; 23:241-244
24. Popov AF, Hosseini MT, Zych B, et al: HeartWare left ventricular assist device implantation through bilateral anterior thoracotomy. Ann Thorac Surg 2012; 93:674-676
25. Tsiouris A, Brewer RJ, Borgi J, et al: Is resternotomy a risk for continuous-flow left ventricular assist device outcomes J Card Surg 2013; 28:82-87
26. Takayama H, Yang JA, Naka Y: Tips on tuning each device: Technical pearls. Cardiol Clin 2011; 29:551-556
27. Selzman CH: Left ventricular assist device insertion. Available at: http://emedicine.medscape.com/article/1839658-overview. Accessed April 29, 2012
28. Thoratec Corporation: Thoratec Corporation Heartmate II LVAS Operating Manual. Pleasanton, CA, Thoratec Corporation, 2010
29. Kikugawa D: Motor current waveforms as an index for evaluation of native cardiac function during left ventricular support with a centrifugal blood pump. Artif Organs 2001; 25:703-708
30. Brassard P, Jensen AS, Nordsborg N, et al: Central and peripheral blood flow during exercise with a continuous-flow left ventricular assist device: Constant versus increasing pump speed: A pilot study. Circ Heart Fail 2011; 4:554-560
31. Salamonsen RF, Mason DG, Ayre PJ: Response of rotary blood pumps to changes in preload and afterload at a fixed speed setting are unphysiological when compared with the natural heart. Artif Organs 2011; 35:E47-E53
32. Andersen M, Gustafsson F, Madsen PL, et al: Hemodynamic stress echocardiography in patients supported with a continuous-flow left ventricular assist device. JACC Cardiovasc Imaging 2010; 3:854-859
33. Jacquet L, Vancaenegem O, Pasquet A, et al: Exercise capacity in patients supported with rotary blood pumps is improved by a spontaneous increase of pump flow at constant pump speed and by a rise in native cardiac output. Artif Organs 2011; 35:682-690
34. Estep JD, Stainback RF, Little SH, et al: The role of echocardiography and other imaging modalities in patients with left ventricular assist devices. JACC Cardiovasc Imaging 2010; 3:1049-1064
35. Karantonis DM, Lovell NH, Ayre PJ, et al: Identification and classification of physiologically significant pumping states in an implantable rotary blood pump. Artif Organs 2006; 30:671-679
36. Jakovljevic DG, George RS, Nunan D, et al: The impact of acute reduction of continuous-flow left ventricular assist device support on cardiac and exercise performance. Heart 2010; 96:1390-1395
37. Martina JR, Westerhof BE, Van Goudoever J, et al: Noninvasive blood pressure measurement by the Nexfin monitor during reduced arterial pulsatility: A feasibility study. ASAIO J 2010; 56:221-227
38. Potapov EV, Loebe M, Nasseri BA, et al: Pulsatile flow in patients with a novel nonpulsatile implantable ventricular assist device. Circulation 2000; 102:III183-III187
39. Bennett MK, Roberts CA, Dordunoo D, et al: Ideal methodology to assess systemic blood pressure in patients with continuousflow left ventricular assist devices. J Heart Lung Transplant 2010; 29:593-594
40. Myers TJ, Bolmers M, Gregoric ID, et al: Assessment of arterial blood pressure during support with an axial flow left ventricular assist device. J Heart Lung Transplant 2009; 28:423-427
41. Hayward CS, Salamonsen R, Keogh AM, et al: Effect of alteration in pump speed on pump output and left ventricular filling with continuous-flow left ventricular assist device. ASAIO J 2011; 57:495-500
42. Anderson CA, Filsoufi F, Aklog L, et al: Liberal use of delayed sternal closure for postcardiotomy hemodynamic instability. Ann Thorac Surg 2002; 73:1484-1488
43. May-Newman K, Enriquez-Almaguer L, Posuwattanakul P, et al: Biomechanics of the aortic valve in the continuous flow VAD-assisted heart. ASAIO J 2010; 56:301-308
44. Rasalingam R, Johnson SN, Bilhorn KR, et al: Transthoracic echocardiographic assessment of continuous-flow left ventricular assist devices. J Am Soc Echocardiogr 2011; 24:135-148
45. Aaronson KD, Slaughter MS, Miller LW, et al: Use of an intrapericardial, continuous-flow, centrifugal pump in patients awaiting heart transplantation. Circulation 2012; 125:3191-3200
46. Kormos RL, Teuteberg JJ, Pagani FD, et al: Right ventricular failure in patients with the HeartMate II continuous-flow left ventricular assist device: Incidence, risk factors, and effect on outcomes. J Thorac Cardiovasc Surg 2010; 139:1316-1324
47. Lee S, Kamdar F, Madlon-Kay R, et al: Effects of the HeartMate II continuous-flow left ventricular assist device on right ventricular function. J Heart Lung Transplant 2010; 29:209-215
48. John R, Liao K, Kamdar F, et al: Effects on pre-and posttransplant pulmonary hemodynamics in patients with continuous-flow left ventricular assist devices. J Thorac Cardiovasc Surg 2010; 140:447-452
49. Kihara S, Kawai A, Fukuda T, et al: Effects of milrinone for right ventricular failure after left ventricular assist device implantation. Heart Vessels 2002; 16:69-71
50. Green EM, Givertz MM: Management of acute right ventricular failure in the intensive care unit. Curr Heart Fail Rep 2012; 9:228-235
51. Feldman D, Pamboukian SV, Teuteberg JJ, et al; International Society for Heart and Lung Transplantation: The 2013 International Society for Heart and Lung Transplantation Guidelines for mechanical circulatory support: Executive summay. J Heart Lung Transplant 2013; 32:157-187
52. Slaughter MS, Pagani FD, Rogers JG, et al: Clinical management of continuous-flow left ventricular assist devices in advanced heart failure. J Heart Lung Transplant 2010; 29:S1-39
53. Tedford RJ, Hemnes AR, Russell SD, et al: PDE5A inhibitor treatment of persistent pulmonary hypertension after mechanical circulatory support. Circ Heart Fail 2008; 1:213-219
54. Scherer M, Sirat AS, Moritz A, et al: Extracorporeal membrane oxygenation as perioperative right ventricular support in patients with biventricular failure undergoing left ventricular assist device implantation. Eur J Cardiothorac Surg 2011; 39:939-944
55. Strueber M, Meyer AL, Malehsa D, et al: Successful use of the HeartWare HVAD rotary blood pump for biventricular support. J Thorac Cardiovasc Surg 2010; 140:936-937
56. Balanos GM, Talbot NP, Dorrington KL, et al: Human pulmonary vascular response to 4 h of hypercapnia and hypocapnia measured using Doppler echocardiography. J Appl Physiol 2003; 94:1543-1551
57. De Lazzari C, Darowski M, Ferrari G, et al: The impact of rotary blood pump in conjunction with mechanical ventilation on ventricular energetic parameters-Numerical simulation. Methods Inf Med 2006; 45:574-583
58. Hasin T, Marmor Y, Kremers W, et al: Readmissions after implantation of axial flow left ventricular assist device. J Am Coll Cardiol 2013; 61:153-163
59. Yuan N, Arnaoutakis GJ, George TJ, et al: The spectrum of complications following left ventricular assist device placement. J Cardiac Surg 2012; 27:63-638
60. John R, Panch S, Hrabe J, et al: Activation of endothelial and coagulation systems in left ventricular assist device recipients. Ann Thorac Surg 2009; 88:1171-1179
61. Meyer AL, Malehsa D, Bara C, et al: Acquired von Willebrand syndrome in patients with an axial flow left ventricular assist device. Circ Heart Fail 2010; 3:675-681
62. Rossi M, Serraino GF, Jiritano F, et al: What is the optimal anticoagulation in patients with a left ventricular assist device Interact Cardiovasc Thorac Surg 2012; 15:733-740
63. Slaughter MS, Sobieski MA 2nd, Graham JD, et al: Platelet activation in heart failure patients supported by the HeartMate II ventricular assist device. Int J Artif Organs 2011; 34:461-468
64. Boyle AJ, Russell SD, Teuteberg JJ, et al: Low thromboembolism and pump thrombosis with the HeartMate II left ventricular assist device: Analysis of outpatient anti-coagulation. J Heart Lung Transplant 2009; 28:881-887
65. Slaughter MS, Naka Y, John R, et al: Post-operative heparin may not be required for transitioning patients with a HeartMate II left ventricular assist system to long-term warfarin therapy. J Heart Lung Transplant 2010; 29:616-624
66. Suarez J, Patel CB, Felker GM, et al: Mechanisms of bleeding and approach to patients with axial-flow left ventricular assist devices. Circ Heart Fail 2011; 4:779-784
67. John R, Kamdar F, Liao K, et al: Low thromboembolic risk for patients with the Heartmate II left ventricular assist device. J Thorac Cardiovasc Surg 2008; 136:1318-1323
68. Kato TS, Ota T, Schulze PC, et al: Asymmetric pattern of cerebrovascular lesions in patients after left ventricular assist device implantation. Stroke 2012; 43:872-874
69. Nakajima I, Kato TS, Komamura K, et al: Pre-and post-operative risk factors associated with cerebrovascular accidents in patients supported by left ventricular assist device. Circ J 2011; 75:1138-1146
70. Pagani FD, Miller LW, Russell SD, et al: Extended mechanical circulatory support with a continuous-flow rotary left ventricular assist device. J Am Coll Cardiol 2009; 54:312-321
71. Aissaoui N, Borgermann J, Gummert J, et al: HeartWare continuousflow ventricular assist device thrombosis: The bad Oeynhausen experience. J Thorac Cardiovasc Surg 2012; 143:e37-e39
72. Rothenburger M, Wilhelm MJ, Hammel D, et al: Treatment of thrombus formation associated with the MicroMed DeBakey VAD using recombinant tissue plasminogen activator. Circulation 2002; 106:I189-I192
73. Tang GH, Kim MC, Pinney SP, et al: Failed repeated thrombolysis requiring left ventricular assist device pump exchange. Catheter Cardiovas Interv 2013; 81:1072-1074
74. Slaughter MS: Hematologic effects of continuous flow left ventricular assist devices. J Cardiov Transl Res 2010; 3:618-624
75. Jessup M, Goldstein D, Ascheim DD, et al: Risk for bleeding after MSCD implant: An analysis of 2358 patients in INTERMACS. J Heart Lung Transplant 2011; 30(Suppl I):S9
76. Genovese EA, Dew MA, Teuteberg JJ, et al: Incidence and patterns of adverse event onset during the first 60 days after ventricular assist device implantation. Ann Thorac Surg 2009; 88:1162-1170
77. Crow S, John R, Boyle A, et al: Gastrointestinal bleeding rates in recipients of nonpulsatile and pulsatile left ventricular assist devices. J Thorac Cardiovasc Surg 2009; 137:208-215
78. Wilson TJ, Stetler WR Jr, Al-Holou WN, et al: Management of intracranial hemorrhage in patients with left ventricular assist devices. J Neurosurg 2013; 118:1063-1068
79. Tsukui H, Abla A, Teuteberg JJ, et al: Cerebrovascular accidents in patients with a ventricular assist device. J Thorac Cardiovasc Surg 2007; 134:114-123
80. Kato TS, Schulze PC, Yang J, et al: Pre-operative and post-operative risk factors associated with neurologic complications in patients with advanced heart failure supported by a left ventricular assist device. J Heart Lung Transplant 2012; 31:1-8
81. Pereira NL, Chen D, Kushwaha SS, et al: Discontinuation of antithrombotic therapy for a year or more in patients with continuous-flow left ventricular assist devices. Interact Cardiovasc Thorac Surg 2010; 11:503-505
82. Saito S, Westaby S, Piggott D, et al: Reliable long-term non-pulsatile circulatory support without anticoagulation. Eur J Cardiothorac Surg 2001; 19:678-683
83. Bruckner BA, DiBardino DJ, Ning Q, et al: High incidence of thromboembolic events in left ventricular assist device patients treated with recombinant activated factor VII. J Heart Lung Transplant 2009; 28:785-790
84. Kirklin JK, Naftel DC, Kormos RL, et al: Second INTERMACS annual report: More than 1,000 primary left ventricular assist device implants. J Heart Lung Transplant 2010; 29:1-10
85. Topkara VK, Kondareddy S, Malik F, et al: Infectious complications in patients with left ventricular assist device: Etiology and outcomes in the continuous-flow era. Ann Thorac Surg 2010; 90:1270-1277
86. Litzler PY, Manrique A, Etienne M, et al: Leukocyte SPECT/CT for detecting infection of left-ventricular-assist devices: Preliminary results. J Nucl Med 2010; 51:1044-1048
87. Acharya MN, Som R, Tsui S: What is the optimum antibiotic prophylaxis in patients undergoing implantation of a left ventricular assist device Interact Cardiovasc Thorac Surg 2012; 14:209-214
88. Chamogeorgakis T, Koval CE, Smedira NG, et al: Outcomes associated with surgical management of infections related to the HeartMate II left ventricular assist device: Implications for destination therapy patients. J Heart Lung Transplant 2012; 31:904-906
89. Holman WL, Rayburn BK, McGiffin DC, et al: Infection in Ventricular assist devices: Prevention and treatment. Ann Thorac Surg 2003; 75:S48-S57.
90. Shafii AE, Chamogeorgakis TP, Gonzalez-Stawinski G: Omental flap transposition with intra-abdominal relocation for LVAD pump-pocket infection. J Heart Lung Transplant 2011; 30:1421-1422
91. Baradarian S, Stahovich M, Krause S,et al: Case series: clinical management of persistent mechanical assist device driveline drainage using vacuum-assisted closure therapy. ASAIO J 2006; 52:354-356
92. Garatt iA, Giuseppe B, Russo CF, et al: Drive-line exit-site infection in a patient with axial-flow pump support: Successful management using vacuum-assisted therapy. J Heart Lung Transplant 2007; 26:956-959
93. Andersen M, Videbaek R, Boesgaard S, et al: Incidence of ventricular arrhythmias in patients on long-term support with a continuousflow assist device (HeartMate II). J Heart Lung Transplant 2009; 28:733-735
94. Boyle A: Arrhythmias in patients with ventricular assist devices. Curr Opin Cardiol 2012; 27:13-18
95. Tuzun E, Rutten M, Dat M, et al: Continuous-flow cardiac assistance: Effects on aortic valve function in a mock loop. J Surg Res 2011; 171:443-447
96. Morgan JA, Paone G, Nemeh HW, et al: Non-cardiac surgery in patients on long-term left ventricular assist device support. J Heart Lung Transplant 2012; 31:757-763
97. Rottenberg EM, Heard J, Hamlin R, et al: Abdominal only CPR during cardiac arrest for a patient with an LVAD during resternotomy: A case report. J Cardiothorac Surg 2011; 6:91
98. Paradis NA, Martin GB, Rivers EP, et al: Coronary perfusion pressure and the return of spontaneous circulation in human cardiopulmonary resuscitation. JAMA 1990; 263:1106-1113
99. Swetz KM, Ottenberg AL, Freeman MR, et al: Palliative care and endof-life issues in patients treated with left ventricular assist devices as destination therapy. Curr Heart Fail Rep 2011; 8:212-218
100. Swetz KM, Mueller PS, Ottenberg AL, et al: The use of advance directives among patients with left ventricular assist devices. Hosp Pract (1995) 2011; 39:78-84